ENGN Q1 2024 Earnings — enGene Holdings Inc. Revenue & Financial Results | Market Cap Arena

ENGNenGene Holdings Inc.

$359M

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$80,000

Operating Income

-$11M

Net Income

-$11M

EPS (Diluted)

$-0.46

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$8M

Stock-Based Comp.

$291,000

Balance Sheet

Total Assets

$93M

Total Liabilities

$31M

Stockholders' Equity

$62M

Cash & Equivalents

$86M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$80,000	$0	—
Operating Income	-$11M	-$5M	-132.5%
Net Income	-$11M	-$7M	-44.4%